Abstract
Comprehensive chemical analysis of extracts and fractions of marine actinomycete strains led to the discovery of a new minor secondary metabolite, salternamide E (1), from a saltern-derived halophilic Streptomyces strain. The planar structure of salternamide E (1) was elucidated by a combinational analysis of spectroscopic data including NMR, MS, UV, and IR. The absolute configuration of salternamide E (1) was determined by circular dichroism spectroscopic analysis. Salternamide E displayed weak cytotoxicity against various human carcinoma cell lines.
REFERENCES
(1). Fenical W., Jensen P. R.Nat. Chem. Biol. 2006; 2:666–673.
(2). Moon K., Chung B., Shin Y., Rheingold A. L., Moore C. E., Park S. J., Park S., Lee S. K., Oh K.-B., Shin J., Oh D.-C. J.Nat. Prod. 2015; 78:524–529.
(3). Hou Y., Braun D. R., Michel C. R., Klassen J. L., Adnani N., Wyche T. P., Bugni T. S.Anal. Chem. 2012; 84:4277–4283.
(4). Forner D., Berrué F., Correa H., Duncan K., Kerr R. G.Anal. Chim. Acta. 2013; 805:70–79.
(5). Yang J. Y., Sanchez L. M., Rath C. M., Liu X., Boudreau P. D., Bruns N., Glukhov E., Wodtke A., de Felicio R., Fenner A., Wong W. R., Linington R. G., Zhang L., Debonsi H. M., Gerwick W. H., Dorrestein P. C. J.Nat. Prod. 2013; 76:1686–1699.
(6). Um S., Kim Y.-J., Kwon H., Wen H., Kim S.-H., Kwon H. C., Park S., Shin J., Oh D.-C. J.Nat. Prod. 2013; 76:873–879.
(7). Um S., Choi T. J., Kim H., Kim B. Y., Kim S.-H., Lee S. K., Oh K.-B., Shin J., Oh D.-C. J.Org. Chem. 2013; 78:12321–12329.
(8). Kwon Y., Kim S.-H., Shin Y., Bae M., Kim B.-Y., Lee S.K.; Oh, K.-B.; Shin, J.; Oh, D.-C. Mar. Drugs. 2014; 12:2326–2340.
(9). Bae M., Kim H., Moon K., Nam S.-J., Shin J., Oh K.-B., Oh D.-C.Org. Lett. 2015; 17:712–715.
(10). Kim S.-H., Shin Y., Lee S.-H., Oh K.-B., Lee S. K., Shin J., Oh D.-C. J.Nat. Prod. 2015; 78:836–843.